Cocrystal Pharma (COCP) Accumulated Expenses (2011 - 2026)
Cocrystal Pharma (COCP) posted Accumulated Expenses of $101000.0 for Q1 2026, up 18.82% sequentially from $85000.0 in Q4 2025, and up 1.0% YoY from $100000.0 in Q1 2025.
Cocrystal Pharma (COCP) Accumulated Expenses (2011 - 2026) Analysis & Trends
Cocrystal Pharma has reported Accumulated Expenses for 15 years, with the latest figure at $101000.0 in Q1 2026.
- Quarterly Accumulated Expenses rose 1.0% year-over-year to $101000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $101000.0 (up 1.0% YoY) and the FY2025 annual result came in at $85000.0, down 27.35% from the prior year.
- Accumulated Expenses rose to $101000.0 in Q1 2026 per COCP's latest filing, from $85000.0 in the prior quarter.
- Over five years, Accumulated Expenses peaked at $185000.0 in Q3 2024 and troughed at $85000.0 in Q4 2025.
- A 5-year average of $132294.1 and a median of $131000.0 in 2022 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2025: Accumulated Expenses increased 25.0% in 2022, then slumped 32.05% in 2025.
- Over 5 years, Accumulated Expenses stood at $130000.0 in 2022, then retreated by 16.15% to $109000.0 in 2023, then increased by 7.34% to $117000.0 in 2024, then declined by 27.35% to $85000.0 in 2025, then gained by 18.82% to $101000.0 in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $101000.0, $85000.0, and $127000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 126,000.00 |
| Mar 31, 2026 | 101,000.00 |
| Dec 31, 2025 | 85,000.00 |
| Sep 30, 2025 | 127,000.00 |
| Jun 30, 2025 | 106,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 117,000.00 |
| Sep 30, 2024 | 185,000.00 |
| Jun 30, 2024 | 156,000.00 |
| Mar 31, 2024 | 139,000.00 |
| Dec 31, 2023 | 109,000.00 |
| Sep 30, 2023 | 173,000.00 |
| Jun 30, 2023 | 150,000.00 |
| Mar 31, 2023 | 131,000.00 |
| Dec 31, 2022 | 130,000.00 |
| Sep 30, 2022 | 165,000.00 |
| Jun 30, 2022 | 144,000.00 |
| Mar 31, 2022 | 131,000.00 |
| Dec 31, 2021 | 104,000.00 |
| Sep 30, 2021 | 158,000.00 |